Introduction
Plasma zinc levels and 24-hr urinary zinc outputs were measured in twenty-four thyrotoxic and ten hypothyroid patients. The findings were related to thyroid status, hormonal parameters, weight changes and to a scale assessing acuteness and severity of the metabolic response to hyper-or hypothyroidism.
Patients and methods
Thirty-four patients with unequivocal clinical evidence and biochemical confirmation of hyper-or hypothyroidism were studied. Hyperthyroid patients were selected on the basis of fairly severe symptomatology, particularly of rapid weight-loss.
Patients were scored on the Wayne Index (Crooks, Murray and Wayne, 1959; Billewicz et al., 1969) as a first approximation of the clinical severity of thyroid malfunction. They were also assessed on a scale designed to give a measure of acuteness and severity of the metabolic response to thyroid overor underactivity (Table 1) . This rating was composed of rate of weight change (amount of weight-gain or loss/duration of symptoms), basal (resting) heart rate, fasting plasma cholesterol, serum thyroxine level and serum triiodothyronine level.
Plasma levels of zinc and 24-hr urinary zinc excretion were measured by the method of Peaston (1973) . This method measures total zinc.
Zinc clearances (ml/min) were calculated as rate of urinary excretion over 24 hr (ml/min) (Ratcliffe, Challano and Ratcliffe, 1974) .
Serum cholesterol was measured on samples obtained after a 12-hr fast by the automated method of Annan and Isherwood (1969) .
Twenty-two patients were studied as out-patients and twelve as in-patients. All (Henry and Elmes, 1975) , few studies have been performed in thyrotoxic patients who would seem to offer a good model for tissue catabolism. One study did report a fall in red cell zinc concentrations in thyrotoxics and considered this a possible specific action of thyroxine on red cell zinc metalloenzymes (Pengaro et al., 1974) . This present investigation has demonstrated a significantly higher zinc output in urine in thyrotoxic patients compared to euthyroid or hypothyroid patients. The increase in zinc clearance in thyrotoxic patients is greater than may be explained by any increase in the creatinine clearance in thyrotoxic patients or by a decrease in euthyroid and hypothyroid patients. The ratio zinc clearance: creatinine clearance is still significantly different in thyrotoxic patients. This would tend to suggest that the increased zinc excretion is not a renal phenomenon but may reflect an increased extracellular fluid zinc loss.
The correlation between clearance and Wayne Index score was poor, possibly because the Index contains items (e.g. ocular signs) that relate more to the underlying pathogenesis of the disorder than to the severity of the metabolic changes induced by elevated hormone levels. The best correlation was with rate of weight-loss and a highly significant correlation with the rating devised to estimate the acuteness and severity of the body's metabolic response to thyrotoxicosis.
No significant correlations were found in the ten hypothyroid patients although five of them had marked weight-gain (> 12-5 kg). The onset of the disorder was insidious and the duration of the disorder uncertain, and this may explain the lack of positive findings. It may be that a study of zinc metabolism in 'acutely' hypothyroid patients would show evidence of zinc retention.
Plasma zinc levels were maintained in thyrotoxic patients (no significant difference from levels in euthyroid controls) despite the increased urinary losses.
The data presented here suggest that urinary zinc losses in thyrotoxicosis are correlated with catabolic status and not a specific effect of thyroid hormones on, say, zinc metalloenyzmes.
It has been suggested that tissue catabolism releases amino acids and other constituents into the circulation; these compounds form stable coordination compounds with zinc. Normally, some 10%°of total plasma zinc exists in this form in equilibrium with a further 60-70% of plasma zinc loosely attached to plasma albumin. The remaining plasma zinc is largely present in chemical combination as part of the metalloprotein a2 macroglobulin (Giroux and Hankin, 1972; Fell, 1975) . The main excretory pathway for zinc is via the gut. Renal losses are in the form of low molecular weight complexes as these alone normally pass the glomerulus. The excessive losses described in severe thyrotoxicosis in this study indicate an increased loss of tissue breakdown products or an alteration in the equilibrium with albumin-bound zinc. It would be of interest to study further the plasma zinc fractions in thyroid disease to clarify this point and to evaluate further the significance of zincuria in thyrotoxicosis.
